Sigma-Tau :: Research

Site Map

About Us Home

Management

News

Community

Products Home

Prescription Products

Consumer Products

Patient Support Home

PhRMA

Research Home

Pipeline

Careers Home

Job Postings

Culture

Benefits

Code of Conduct

Corporate Compliance Program

Declaration of Compliance

Sigma-Tau Pharmaceuticals, Inc. is a research-based pharmaceutical company focused on the discovery of molecules and therapies to help improve the lives of people who suffer from rare diseases.

This product information is intended for U.S. residents only. You should not construe anything on this site as a promotion or solicitation for any product or for the use of any product outside the United States.

Research Pipeline
Development Program	Indication	Development Stage

Cystoran^TM (cysteamine hydrochloride ophthalmic solution) 0.55%	Treatment of ocular crystals for patients with cystinosis	Phase III
Defibrotide in severe Venous Occlusive Disease	Treatment of Severe Hepatic Venous Occlusive Disease after stem cell transplantation	Phase III
IV Artesunate in Severe Malaria	Immediate treatment of severe and complicated falciparum malaria	Phase III